Pages that link to "Q64379610"
Jump to navigation
Jump to search
The following pages link to Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries (Q64379610):
Displaying 10 items.
- Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model (Q28185689) (← links)
- Engineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo (Q33316622) (← links)
- Platelets, atherosclerosis and the endothelium: new therapeutic targets? (Q35570940) (← links)
- Cardiovascular gene delivery: The good road is awaiting (Q35915765) (← links)
- Central role of Sp1-regulated CD39 in hypoxia/ischemia protection (Q37039131) (← links)
- The calcium activated nucleotidases: A diverse family of soluble and membrane associated nucleotide hydrolyzing enzymes (Q37135540) (← links)
- Dynamic purine signaling and metabolism during neutrophil-endothelial interactions (Q37135563) (← links)
- The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active (Q40121574) (← links)
- Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty. (Q41761170) (← links)
- Human solCD39 inhibits injury-induced development of neointimal hyperplasia (Q82300172) (← links)